Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

AstraZeneca

32 posts
RRoche
Roche Towers, Basel, Switzerland
Read More

Roche–Hansoh ADC deal: $400M upfront, $15B+ milestones

  • 2026-10-20
Roche Towers in Basel, Switzerland. [Adobe Stock] Roche is expanding a string of deals with Chinese drugmakers, committing…
NNovartis
Novartis pays $575 million upfront for Abogen's mRNA autoimmune therapy in deal worth up to $7.8 billion — BigGo Finance
Read More

Novartis pays $575 million upfront for Abogen’s mRNA autoimmune therapy in deal worth up to $7.8 billion — BigGo Finance

  • 2026-10-02
A Chinese biotech firm has landed one of the largest licensing deals ever struck for an mRNA-based therapy,…
UUBS
AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies
Read More

AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies

  • 2026-09-29
AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies Proactive uses images sourced from Shutterstock AstraZeneca…
UUBS
AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies
Read More

AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies

  • 2026-09-29
AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies Proactive uses images sourced from Shutterstock AstraZeneca…
UUBS
AstraZeneca shares oversold after trial flops and merger talk, says UBS
Read More

AstraZeneca shares oversold after trial flops and merger talk, says UBS

  • 2026-09-22
AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive uses images sourced from Shutterstock UBS…
UUBS
AstraZeneca shares oversold after trial flops and merger talk, says UBS
Read More

AstraZeneca shares oversold after trial flops and merger talk, says UBS

  • 2026-09-16
AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive uses images sourced from Shutterstock UBS…
NNovartis
Novartis Erases $40B in a Week, and the Lp(a) Race Now Has One Question: Antisense or siRNA? — BigGo Finance
Read More

Novartis Erases $40B in a Week, and the Lp(a) Race Now Has One Question: Antisense or siRNA? — BigGo Finance

  • 2026-09-15
Novartis entered September 2026 as one of the best-performing large-cap pharma companies on the planet — “one of…
NNovartis
FDA Halts SK Biopharm's OPCALIM; Novartis' $12 Billion Drug Fails Phase 3 — BigGo Finance
Read More

FDA Halts SK Biopharm’s OPCALIM; Novartis’ $12 Billion Drug Fails Phase 3 — BigGo Finance

  • 2026-09-11
The partial clinical hold imposed by the U.S. Food and Drug Administration (FDA) on OPCALIM (BHV-7000), an epilepsy…
NNovartis
Neil Jones and Phil Masterson: The Charity Model Behind a $1.5B Novartis Deal — BigGo Finance
Read More

Neil Jones and Phil Masterson: The Charity Model Behind a $1.5B Novartis Deal — BigGo Finance

  • 2026-09-04
The news that Novartis agreed to pay up to $1.5 billion for a little-known British biotech called MyRix…
RRoche
Roche tops cancer reputation rankings as AstraZeneca climbs back
Read More

Roche tops cancer reputation rankings as AstraZeneca climbs back

  • 2026-08-19
AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back…
GGlencore
British Business Headlines: GSK Investment, Burberry Stake, AstraZeneca Challenges, Glencore Allegations, Football Deal Talks
Read More

British Business Headlines: GSK Investment, Burberry Stake, AstraZeneca Challenges, Glencore Allegations, Football Deal Talks

  • 2026-07-29
In a significant economic development, pharma giant GSK announced plans to establish a global research and development headquarters…
NNovartis
Novartis Earnings Preview: Can New Medicines Offset Generic Pressure and Growing U.S. Pricing Risks?
Read More

Novartis Earnings Preview: Can New Medicines Offset Generic Pressure and Growing U.S. Pricing Risks?

  • 2026-07-20
Novartis’ shift toward high-innovation pharmaceuticals has made regulatory milestones, late-stage trial results, and new product rollouts top priorities…
Switzerland
www.europesays.com